List of causes of death by rate

The following is a list of the causes of human deaths worldwide for different years arranged by their associated mortality rates. In 2002, there were about 57 million deaths. In 2005, according to the World Health Organization (WHO) using the International Statistical Classification of Diseases and Related Health Problems (ICD), about 58 million people died.[1] In 2010, according to the Institute for Health Metrics and Evaluation, 52.8 million people died.[2] In 2016, the WHO recorded 56.7 million deaths[3] with the leading cause of death as cardiovascular disease causing more than 17 million deaths (about 31% of the total) as shown in the chart to the side.

Further information: Cause of death
Leading cause of death (2016) (world)

Some causes listed include deaths also included in more specific subordinate causes, and some causes are omitted, so the percentages may only sum approximately to 100%. The causes listed are relatively immediate medical causes, but the ultimate cause of death might be described differently. For example, tobacco smoking often causes lung disease or cancer, and alcohol use disorder can cause liver failure or a motor vehicle accident. For statistics on preventable ultimate causes, see preventable causes of death.

Besides frequency, other measures to compare, consider and monitor trends of causes of deaths include disability-adjusted life year (DALY) and years of potential life lost (YPLL).

By frequency

Age standardized death rate, per 100,000, by cause, in 2017, and percentage change 2007–2017.[4]

Overview table

This first table gives a convenient overview of the general categories and broad causes. The leading cause is cardiovascular disease at 31.59% of all deaths.

Category Cause Percent of all
deaths		 Percent of all
deaths
I. Communicable, maternal, neonatal,
and nutritional disorders		Respiratory infections and tuberculosis6.8519.49%
Enteric infections3.31
Sexually transmitted infections1.88
Tropical diseases and malaria1.37
Other infectious diseases1.57
Maternal and neonatal disorders4.00
Nutritional deficiencies0.52
II. Non-communicable diseasesCardiovascular diseases31.5972.67%
Neoplasms16.43
Chronic respiratory diseases6.97
Digestive diseases4.11
Neurological disorders5.84
Substance abuse0.58
Diabetes and kidney diseases4.55
Skin diseases0.18
Musculoskeletal disorders0.22
Other non-communicable2.22
III. InjuriesTransport injuries2.307.85%
Unintentional injuries3.23
Self harm and violence2.32
Total100%100%

Detailed table

This second table gives a more detailed and specific breakdown of the causes.

Age-standardised Death Rate (per 100,000) in 2017
CauseRatePercent of all deathsPercent Change 2007–2017
All causes737.7
(729.9 to 745.4)		100%-14.2
(-15.0 to -13.5)
I. Communicable, maternal, neonatal, and nutritional disorders143.8
(138.4 to 151.6)		19.49%-31.8
(-33.3 to -30.1)
Respiratory infections and tuberculosis50.5
(48.8 to 52.3)		6.85%-24.5
(-26.4 to -22.6)
Tuberculosis 14.9
(14.3 to 15.7)		2.02%-31.4
(-34.1 to -27.6)
Drug-susceptible tuberculosis13.2
(12.0 to 14.2)		1.79%-31.9
(-37.3 to -26.4)
Multidrug-resistant tuberculosis without extensive drug resistance1.6
(0.9 to 2.5)		0.22%-28.6
(-57.4 to 11.4)
Extensively drug-resistant tuberculosis0.2
(0.1 to 0.2)		0.03%-7.7
(-34.1 to 28.8)
Lower respiratory infections 35.4
(33.8 to 36.8)		4.80%-21.1
(-23.2 to -18.9)
Upper respiratory infections 0.1
(0.1 to 0.2)		0.01%-42.1
(-49.6 to -29.9)
Otitis media 0.0
(0.0 to 0.0)		0.00%-50.4
(-58.8 to -39.9)
Enteric infections24.4
(19.5 to 32.4)		3.31%-29.9
(-34.9 to -23.1)
Diarrhoeal diseases21.6
(16.4 to 29.7)		2.93%-30.2
(-36.1 to -22.7)
Typhoid and paratyphoid1.9
(1.1 to 3.0)		0.26%-27.8
(-32.8 to -23.9)
(Typhoid fever)1.6
(0.9 to 2.6)		0.22%-29.1
(-34.1 to -25.0)
(Paratyphoid fever)0.3
(0.1 to 0.5)		0.04%-18.9
(-26.1 to -10.8)
iNTS0.8
(0.5 to 1.4)		0.11%-24.8
(-31.9 to -15.6)
Other intestinal infectious diseases0.0
(0.0 to 0.0)		0.00%-44.7
(-70.1 to 2.3)
Sexually transmitted infections13.9
(12.6 to 15.5)		1.88%-53.6
(-55.8 to -51.0)
HIV/AIDS 12.1
(11.5 to 12.9)		1.64%-56.5
(-58.0 to -54.7)
HIV/AIDS – Drug-susceptible Tuberculosis2.5
(1.8 to 3.2)		0.34%-61.1
(-63.7 to -57.7)
HIV/AIDS – Multidrug-resistant Tuberculosis without extensive drug resistance0.3
(0.2 to 0.4)		0.04%-58.1
(-70.5 to -41.5)
HIV/AIDS – Extensively drug-resistant Tuberculosis0.0
(0.0 to 0.0)		0.00%-20.3
(-36.4 to -0.2)
HIV/AIDS resulting in other diseases9.3
(8.4 to 10.4)		1.26%-55.1
(-57.2 to -52.6)
Sexually transmitted infections excluding HIV 1.8
(0.7 to 3.3)		0.24%-14.4
(-21.5 to -6.6)
Syphilis1.7
(0.7 to 3.2)		0.23%-14.3
(-21.8 to -6.4)
Chlamydial infection0.0
(0.0 to 0.0)		0.00%-15.2
(-21.0 to -8.4)
Gonococcal infection0.0
(0.0 to 0.0)		0.00%-14.9
(-20.8 to -8.2)
Other sexually transmitted infections0.0
(0.0 to 0.0)		0.00%-15.9
(-21.6 to -9.5)
Neglected tropical diseases and malaria10.1
(7.5 to 13.2)		1.37%-36.1
(-43.7 to -27.3)
Malaria8.7
(6.1 to 11.9)		1.18%-37.3
(-45.4 to -27.9)
Chagas disease0.1
(0.1 to 0.1)		0.01%-21.1
(-25.2 to -14.3)
Leishmaniasis0.1
(0.0 to 0.5)		0.01%-67.8
(-97.5 to -50.3)
(Visceral leishmaniasis)0.1
(0.0 to 0.5)		0.01%-67.8
(-97.5 to -50.3)
African trypanosomiasis (sleeping sickness)0.0
(0.0 to 0.1)		0.00%-82.8
(-96.0 to -34.3)
Schistosomiasis0.1
(0.1 to 0.1)		0.01%-28.5
(-32.7 to -23.7)
Cysticercosis0.0
(0.0 to 0.0)		0.00%-27.3
(-50.5 to 5.3)
Cystic echinococcosis0.0
(0.0 to 0.0)		0.00%-41.9
(-59.8 to -19.0)
Dengue0.5
(0.2 to 0.7)		0.07%40.7
(3.6 to 69.7)
Yellow fever0.1
(0.0 to 0.2)		0.01%-23.3
(-34.4 to -9.6)
Rabies0.2
(0.1 to 0.2)		0.03%-54.8
(-63.8 to -45.0)
Intestinal nematode infections0.0
(0.0 to 0.1)		0.00%-47.2
(-59.5 to -30.1)
(Ascariasis)0.0
(0.0 to 0.1)		0.00%-47.2
(-59.5 to -30.1)
Ebola virus disease0.0
(0.0 to 0.0)		0.00%-98.4
(-98.4 to -98.4)
Zika virus disease0.0
(0.0 to 0.0)		0.00%-
Other neglected tropical diseases0.2
(0.1 to 0.5)		0.03%-3.7
(-18.3 to 13.9)
Other infectious diseases11.6
(10.1 to 13.3)		1.57%-33.8
(-39.3 to -27.4)
Meningitis 4.0
(3.6 to 4.6)		0.54%-27.8
(-33.1 to -19.3)
Pneumococcal meningitis0.6
(0.5 to 0.7)		0.08%-22.4
(-28.9 to -12.4)
H influenzae type B meningitis1.1
(0.9 to 1.3)		0.15%-40.6
(-45.8 to -33.9)
Meningococcal infection0.4
(0.4 to 0.5)		0.05%-37.1
(-42.6 to -29.2)
Other meningitis2.0
(1.7 to 2.3)		0.27%-17.3
(-23.4 to -7.5)
Encephalitis 1.2
(1.1 to 1.4)		0.16%-14.3
(-26.5 to -0.9)
Diphtheria 0.1
(0.0 to 0.1)		0.01%-28.6
(-58.8 to 29.2)
Whooping cough (pertussis) 1.4
(0.7 to 2.4)		0.19%-27.1
(-57.1 to 28.8)
Tetanus 0.5
(0.4 to 0.7)		0.07%-59.6
(-69.3 to -45.0)
Measles 1.4
(0.5 to 3.1)		0.19%-59.3
(-64.0 to -54.4)
Varicella (chickenpox) and herpes zoster (shingles) 0.2
(0.2 to 0.2)		0.03%-29.2
(-34.7 to -23.4)
Acute hepatitis 1.6
(1.2 to 1.9)		0.22%-24.5
(-29.2 to -18.4)
Acute hepatitis A0.3
(0.2 to 0.3)		0.04%-38.7
(-46.8 to -28.6)
Acute hepatitis B1.1
(0.8 to 1.3)		0.15%-19.6
(-25.4 to -12.4)
Acute hepatitis C0.0
(0.0 to 0.1)		0.00%-32.1
(-42.4 to -19.6)
Acute hepatitis E0.2
(0.1 to 0.2)		0.03%-25.8
(-35.3 to -15.6)
Other unspecified infectious diseases 1.1
(0.8 to 1.2)		0.15%-13.4
(-17.5 to -8.1)
Maternal and neonatal disorders29.5
(28.2 to 30.8)		4.00%-26.6
(-29.3 to -23.5)
Maternal disorders 2.5
(2.3 to 2.7)		0.34%-30.7
(-34.8 to -26.6)
Maternal haemorrhage0.5
(0.4 to 0.6)		0.07%-56.4
(-62.7 to -49.3)
Maternal sepsis and other pregnancy related infections
(e.g. Postpartum infections)		0.3
(0.2 to 0.3)		0.04%-33.5
(-44.2 to -22.6)
Maternal hypertensive disorders0.4
(0.3 to 0.4)		0.05%-13.0
(-27.3 to 2.6)
Maternal obstructed labour and uterine rupture0.2
(0.1 to 0.2)		0.03%-25.2
(-41.0 to -6.3)
Maternal abortive outcome0.2
(0.2 to 0.3)		0.03%-15.7
(-29.3 to -0.4)
Ectopic pregnancy0.1
(0.1 to 0.2)		0.01%-19.2
(-46.2 to 16.8)
Indirect maternal deaths0.4
(0.4 to 0.5)		0.05%-12.5
(-24.0 to -1.0)
Late maternal deaths0.0
(0.0 to 0.1)		0.00%-9.5
(-14.7 to -4.0)
Maternal deaths aggravated by HIV/AIDS0.0
(0.0 to 0.0)		0.00%-32.1
(-38.4 to -25.2)
Other maternal disorders0.3
(0.3 to 0.4)		0.04%-16.5
(-31.2 to 1.5)
Neonatal disorders 27.1
(25.8 to 28.3)		3.67%-26.2
(-29.1 to -22.7)
Neonatal preterm birth9.9
(9.2 to 10.9)		1.34%-28.1
(-33.2 to -23.6)
Neonatal encephalopathy due to birth asphyxia and trauma8.1
(7.2 to 8.8)		1.10%-26.5
(-32.0 to -20.2)
Neonatal sepsis and other neonatal infections3.1
(2.7 to 4.1)		0.42%-14.4
(-22.7 to -4.4)
Hemolytic disease and other neonatal jaundice0.7
(0.7 to 0.8)		0.09%-39.3
(-46.8 to -30.2)
Other neonatal disorders5.3
(4.5 to 5.8)		0.72%-25.7
(-31.7 to -17.8)
Nutritional deficiencies3.8
(3.5 to 4.2)		0.52%-33.6
(-38.1 to -26.5)
Protein-energy malnutrition3.3
(3.0 to 3.7)		0.45%-34.6
(-39.4 to -27.5)
Other nutritional deficiencies0.5
(0.4 to 0.6)		0.07%-25.8
(-31.7 to -17.5)
II. Non-communicable diseases536.1
(528.4 to 542.2)		72.67%-7.9
(-8.8 to -7.0)
Cardiovascular diseases233.1
(229.7 to 236.4)		31.60%-10.3
(-11.4 to -9.3)
Rheumatic heart disease3.7
(3.4 to 3.9)		0.50%-21.3
(-25.2 to -17.8)
Ischaemic heart disease116.9
(115.1 to 119.7)		15.85%-9.7
(-11.0 to -8.7)
Stroke 80.5
(78.9 to 82.6)		10.91%-13.6
(-15.0 to -12.1)
Ischaemic stroke36.6
(35.5 to 38.0)		4.96%-11.8
(-13.4 to -10.3)
Intracerebral hemorrhage38.2
(37.0 to 39.4)		5.18%-15.7
(-17.8 to -13.8)
Subarachnoid hemorrhage5.7
(5.3 to 6.3)		0.77%-9.4
(-13.1 to -4.9)
Hypertensive heart disease 12.3
(9.0 to 13.2)		1.67%7.5
(-7.3 to 16.3)
Non-rheumatic valvular heart disease 2.0
(1.6 to 2.0)		0.27%-5.3
(-7.9 to -3.2)
Non-rheumatic calcific aortic valve disease1.4
(1.1 to 1.5)		0.19%-1.0
(-5.6 to 2.2)
Non-rheumatic degenerative mitral valve disease0.5
(0.4 to 0.6)		0.07%-14.0
(-18.1 to -8.6)
Other non-rheumatic valve diseases0.1
(0.1 to 0.1)		0.01%-17.8
(-28.5 to 8.0)
Cardiomyopathy and myocarditis 4.8
(4.5 to 5.0)		0.65%-16.6
(-19.8 to -9.4)
Myocarditis0.6
(0.5 to 0.7)		0.08%-13.3
(-20.4 to -0.1)
Alcoholic cardiomyopathy1.1
(1.0 to 1.2)		0.15%-40.5
(-43.7 to -27.6)
Other cardiomyopathy3.1
(2.8 to 3.3)		0.42%-3.6
(-6.7 to -0.7)
Atrial fibrillation and flutter 4.0
(3.9 to 4.2)		0.54%2.6
(0.9 to 4.6)
Aortic aneurysm 2.2
(2.1 to 2.3)		0.30%-8.5
(-11.2 to -5.8)
Peripheral vascular disease 1.0
(0.6 to 1.7)		0.14%10.5
(-6.8 to 24.1)
Endocarditis 1.1
(1.0 to 1.2)		0.15%1.0
(-4.0 to 5.0)
Other cardiovascular and circulatory diseases 4.7
(4.4 to 5.1)		0.64%-7.9
(-10.9 to -5.9)
Neoplasms121.2
(119.1 to 122.9)		16.43%-4.4
(-5.6 to -3.3)
Lip and oral cavity cancer2.4
(2.3 to 2.5)		0.33%4.0
(-0.6 to 8.0)
Nasopharynx cancer0.9
(0.8 to 0.9)		0.12%-3.0
(-6.4 to 0.4)
Other pharynx cancer1.4
(1.3 to 1.5)		0.19%7.9
(-0.3 to 14.0)
Oesophageal cancer5.5
(5.3 to 5.6)		0.75%-14.5
(-16.9 to -12.0)
Stomach cancer11.0
(10.8 to 11.2)		1.49%-17.1
(-18.8 to -15.1)
Colon and rectum cancer11.5
(11.3 to 11.8)		1.56%-4.3
(-7.1 to -1.8)
Liver cancer10.2
(9.8 to 10.7)		1.38%-2.5
(-5.6 to 2.0)
(Liver cancer due to hepatitis B)4.0
(3.7 to 4.3)		0.54%-6.2
(-10.0 to 0.1)
(Liver cancer due to hepatitis C)3.0
(2.8 to 3.2)		0.41%-2.1
(-4.9 to 1.4)
(Liver cancer due to alcohol use)1.6
(1.4 to 1.8)		0.22%0.6
(-3.0 to 4.8)
(Liver cancer due to NASH)0.8
(0.8 to 0.9)		0.11%7.6
(4.4 to 11.7)
(Liver cancer due to other causes)0.8
(0.7 to 0.9)		0.11%-0.9
(-4.2 to 3.6)
Gallbladder and biliary tract cancer2.2
(2.0 to 2.4)		0.30%-6.7
(-9.4 to -4.0)
Pancreatic cancer5.6
(5.5 to 5.7)		0.76%4.8
(2.5 to 6.8)
Larynx cancer1.6
(1.5 to 1.6)		0.22%-7.7
(-10.1 to -5.2)
Tracheal, bronchus, and lung cancer23.7
(23.3 to 24.2)		3.21%-2.0
(-4.3 to 0.1)
Malignant skin melanoma0.8
(0.6 to 0.9)		0.11%-5.1
(-8.5 to -2.5)
Non-melanoma skin cancer0.8
(0.8 to 0.9)		0.11%2.7
(0.0 to 4.5)
(Non-melanoma skin cancer (squamous-cell carcinoma))0.8
(0.8 to 0.9)		0.11%2.7
(0.0 to 4.5)
Breast cancer7.6
(7.4 to 8.0)		1.03%-2.6
(-6.9 to 0.4)
Cervical cancer3.2
(3.0 to 3.3)		0.43%-7.2
(-11.7 to -4.0)
Uterine cancer1.1
(1.0 to 1.1)		0.15%-10.4
(-12.5 to -7.7)
Ovarian cancer2.2
(2.1 to 2.3)		0.30%-1.0
(-3.6 to 1.6)
Prostate cancer5.5
(4.7 to 6.5)		0.75%-2.5
(-4.9 to 1.9)
Testicular cancer0.1
(0.1 to 0.1)		0.01%-9.4
(-12.6 to -5.2)
Kidney cancer1.8
(1.6 to 1.8)		0.24%-1.3
(-4.3 to 1.7)
Bladder cancer2.6
(2.5 to 2.7)		0.35%-5.4
(-7.3 to -3.4)
Brain and nervous system cancer3.1
(2.7 to 3.3)		0.42%3.8
(-1.0 to 7.0)
Thyroid cancer0.5
(0.5 to 0.6)		0.07%-1.2
(-4.5 to 2.0)
Mesothelioma0.4
(0.4 to 0.4)		0.05%-3.4
(-8.4 to 0.7)
Hodgkin lymphoma0.4
(0.4 to 0.5)		0.05%-16.8
(-19.8 to -14.0)
Non-Hodgkin's lymphoma3.2
(3.1 to 3.2)		0.43%0.1
(-2.7 to 2.4)
Multiple myeloma1.4
(1.3 to 1.5)		0.19%-0.4
(-3.5 to 2.4)
Leukaemia 4.5
(4.1 to 4.7)		0.61%-9.6
(-12.2 to -7.4)
Acute lymphoid leukaemia0.7
(0.6 to 0.7)		0.09%-1.5
(-11.6 to 6.2)
Chronic lymphoid leukaemia0.5
(0.4 to 0.5)		0.07%-10.3
(-13.0 to -7.6)
Acute myeloid leukaemia1.3
(1.2 to 1.3)		0.18%-1.0
(-6.6 to 3.0)
Chronic myeloid leukaemia0.3
(0.3 to 0.3)		0.04%-19.9
(-22.2 to -17.6)
Other leukaemia1.8
(1.6 to 1.9)		0.24%-15.6
(-18.7 to -12.1)
Other malignant cancers 4.6
(4.2 to 4.8)		0.62%0.1
(-2.6 to 2.2)
Other neoplasms 1.3
(1.0 to 1.6)		0.18%7.4
(2.1 to 15.8)
Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms1.3
(1.0 to 1.5)		0.18%7.1
(1.8 to 15.3)
Other benign and in situ neoplasms0.1
(0.0 to 0.1)		0.01%15.5
(4.1 to 29.2)
Chronic respiratory diseases51.4
(49.7 to 53.1)		6.97%-14.2
(-16.5 to -11.5)
Chronic obstructive pulmonary disease42.2
(40.0 to 44.2)		5.72%-13.6
(-16.5 to -11.0)
Pneumoconiosis0.3
(0.3 to 0.3)		0.04%-16.7
(-20.8 to -12.4)
(Silicosis)0.1
(0.1 to 0.2)		0.01%-15.5
(-23.6 to -7.4)
(Asbestosis)0.0
(0.0 to 0.1)		0.00%-8.3
(-14.1 to -0.4)
(Coal workers pneumoconiosis)0.0
(0.0 to 0.1)		0.00%-26.6
(-33.8 to -16.7)
(Other pneumoconiosis)0.0
(0.0 to 0.1)		0.00%-17.5
(-24.1 to -5.0)
Asthma6.3
(4.3 to 8.2)		0.85%-23.9
(-28.1 to -17.2)
Interstitial lung disease and pulmonary sarcoidosis1.9
(1.5 to 2.4)		0.26%11.4
(4.0 to 17.9)
Other chronic respiratory diseases0.7
(0.6 to 0.8)		0.09%-3.2
(-8.7 to 6.7)
Digestive diseases30.3
(29.2 to 32.1)		4.11%-10.7
(-13.1 to -7.3)
Cirrhosis and other chronic liver diseases 16.5
(15.8 to 18.1)		2.24%-9.7
(-14.7 to -4.6)
Cirrhosis and other chronic liver diseases due to hepatitis B4.8
(4.3 to 5.5)		0.65%-14.3
(-20.2 to -7.3)
Cirrhosis and other chronic liver diseases due to hepatitis C4.2
(3.9 to 4.7)		0.57%-8.4
(-13.0 to -3.9)
Cirrhosis and other chronic liver diseases due to alcohol use4.1
(3.7 to 4.6)		0.56%-8.8
(-13.2 to -3.4)
Cirrhosis due to NASH1.5
(1.3 to 1.6)		0.20%-1.4
(-6.3 to 3.1)
Cirrhosis and other chronic liver diseases due to other causes1.9
(1.7 to 2.1)		0.26%-8.6
(-13.4 to -3.8)
Upper digestive system diseases 3.8
(3.6 to 4.0)		0.52%-21.6
(-24.8 to -17.3)
Peptic ulcer disease3.1
(3.0 to 3.3)		0.42%-23.5
(-26.6 to -19.7)
Gastritis and duodenitis0.7
(0.6 to 0.7)		0.09%-11.7
(-17.6 to -2.2)
Appendicitis 0.6
(0.5 to 0.6)		0.08%-17.0
(-21.5 to -10.7)
Paralytic ileus and intestinal obstruction 3.2
(2.7 to 3.5)		0.43%-5.8
(-11.0 to 0.3)
Inguinal, femoral, and abdominal hernia 0.6
(0.5 to 0.7)		0.08%-8.9
(-12.9 to -4.2)
Inflammatory bowel disease 0.5
(0.4 to 0.5)		0.07%-10.5
(-16.0 to -5.9)
Vascular intestinal disorders 1.3
(1.2 to 1.3)		0.18%-10.2
(-14.2 to -6.2)
Gallbladder and biliary diseases 1.5
(1.4 to 1.6)		0.20%-5.0
(-7.5 to -1.7)
Pancreatitis 1.3
(1.1 to 1.4)		0.18%-5.7
(-9.0 to -1.7)
Other digestive diseases 1.2
(1.1 to 1.2)		0.16%-7.1
(-12.1 to -2.4)
Neurological disorders43.1
(42.3 to 43.7)		5.84%0.1
(-1.2 to 1.3)
Alzheimer's disease and other dementias35.4
(34.8 to 35.9)		4.80%0.6
(-0.9 to 1.8)
Parkinson's disease4.6
(4.4 to 4.8)		0.62%0.8
(-2.8 to 3.0)
Epilepsy1.7
(1.5 to 2.0)		0.23%-10.7
(-15.4 to -0.5)
Multiple sclerosis0.3
(0.2 to 0.3)		0.04%-3.9
(-14.5 to 0.4)
Motor neuron disease0.4
(0.4 to 0.5)		0.05%1.2
(-2.4 to 4.5)
Other neurological disorders0.7
(0.7 to 0.8)		0.09%2.0
(-3.9 to 6.8)
Mental disorders0.0
(0.0 to 0.0)		0.00%7.5
(-1.4 to 15.9)
Eating disorders 0.0
(0.0 to 0.0)		0.00%7.5
(-1.4 to 15.9)
Anorexia nervosa0.0
(0.0 to 0.0)		0.00%5.5
(-4.1 to 14.4)
Bulimia nervosa0.0
(0.0 to 0.0)		0.00%13.5
(1.0 to 26.2)
Substance use disorders4.3
(4.1 to 4.5)		0.58%2.0
(-1.0 to 5.0)
Alcohol use disorders 2.3
(2.0 to 2.4)		0.31%-16.5
(-20.4 to -12.4)
Drug use disorders 2.1
(2.0 to 2.1)		0.28%34.1
(31.4 to 36.9)
Opioid use disorders1.4
(1.3 to 1.4)		0.19%49.4
(42.5 to 59.2)
Cocaine use disorders0.1
(0.1 to 0.1)		0.01%19.6
(9.2 to 33.0)
Amphetamine use disorders0.1
(0.0 to 0.1)		0.01%8.7
(-14.0 to 20.7)
Other drug use disorders0.6
(0.5 to 0.6)		0.08%11.3
(1.2 to 19.9)
Diabetes and kidney diseases33.6
(32.9 to 34.3)		4.55%1.3
(-0.3 to 2.7)
Diabetes mellitus 17.5
(17.1 to 17.9)		2.37%1.2
(-0.7 to 3.1)
Diabetes mellitus type 14.3
(4.0 to 4.7)		0.58%-11.0
(-14.6 to -7.8)
Diabetes mellitus type 213.2
(12.7 to 13.7)		1.79%5.9
(4.1 to 8.0)
Chronic kidney disease 15.9
(15.5 to 16.3)		2.16%1.5
(-0.9 to 3.2)
Chronic kidney disease due to diabetes mellitus type 10.9
(0.8 to 1.2)		0.12%-1.2
(-4.0 to 1.2)
Chronic kidney disease due to diabetes mellitus type 24.5
(4.0 to 5.1)		0.61%4.2
(1.4 to 6.2)
Chronic kidney disease due to hypertension4.6
(4.0 to 5.2)		0.62%3.2
(0.4 to 5.2)
Chronic kidney disease due to glomerulonephritis2.4
(2.1 to 2.8)		0.33%-1.3
(-3.2 to 0.7)
Chronic kidney disease due to other and unspecified causes3.4
(3.0 to 3.9)		0.46%-1.4
(-3.7 to 0.6)
Acute glomerulonephritis 0.1
(0.1 to 0.2)		0.01%-9.5
(-14.5 to -3.5)
Skin and subcutaneous diseases1.3
(0.9 to 1.7)		0.18%8.1
(2.7 to 16.5)
Bacterial skin diseases1.0
(0.6 to 1.3)		0.14%12.7
(6.0 to 20.7)
(Cellulitis)0.2
(0.1 to 0.3)		0.03%19.6
(9.8 to 28.2)
(Pyoderma)0.8
(0.5 to 0.9)		0.11%10.5
(3.2 to 19.0)
Decubitus ulcer0.3
(0.2 to 0.4)		0.04%-5.1
(-12.2 to 9.2)
Other skin and subcutaneous diseases0.1
(0.0 to 0.1)		0.01%3.3
(-3.5 to 14.4)
Musculoskeletal disorders1.6
(1.4 to 1.6)		0.22%-0.1
(-4.4 to 3.2)
Rheumatoid arthritis0.6
(0.5 to 0.7)		0.08%-5.9
(-12.9 to -1.2)
Other musculoskeletal disorders1.0
(0.9 to 1.0)		0.14%3.9
(0.9 to 7.5)
Other non-communicable diseases16.3
(15.5 to 17.1)		2.21%-11.2
(-15.3 to -8.5)
Congenital anomalies 8.7
(8.2 to 9.2)		1.18%-18.2
(-24.7 to -14.1)
Neural tube defects0.9
(0.7 to 1.3)		0.12%-16.5
(-27.6 to -4.8)
Congenital heart anomalies3.9
(3.2 to 4.6)		0.53%-21.8
(-28.1 to -14.1)
Orofacial clefts0.1
(0.0 to 0.1)		0.01%-41.9
(-55.9 to -25.1)
Down syndrome0.4
(0.3 to 0.5)		0.05%-5.2
(-14.2 to 7.0)
Other chromosomal abnormalities0.3
(0.2 to 0.4)		0.04%0.3
(-10.1 to 13.2)
Congenital musculoskeletal and limb anomalies0.2
(0.1 to 0.2)		0.03%-12.8
(-20.9 to -4.5)
Urogenital congenital anomalies0.2
(0.1 to 0.2)		0.03%-8.5
(-17.1 to 2.1)
Digestive congenital anomalies0.8
(0.6 to 1.1)		0.11%-19.3
(-29.8 to -9.8)
Other congenital anomalies2.1
(1.5 to 2.6)		0.28%-15.9
(-23.3 to -4.5)
Urinary diseases and male infertility 3.6
(3.5 to 3.7)		0.49%5.7
(2.2 to 8.5)
Urinary tract infections2.7
(2.6 to 3.0)		0.37%10.9
(7.2 to 14.5)
Urolithiasis (Kidney stone disease)0.2
(0.1 to 0.2)		0.03%-1.2
(-9.7 to 12.9)
Other urinary diseases0.7
(0.6 to 0.8)		0.09%-9.9
(-15.3 to -2.2)
Gynecological diseases 0.1
(0.1 to 0.1)		0.01%-2.6
(-13.6 to 6.0)
Uterine fibroids0.0
(0.0 to 0.0)		0.00%8.1
(-14.9 to 24.7)
Polycystic ovarian syndrome0.0
(0.0 to 0.0)		0.00%1.0
(-22.5 to 34.8)
Endometriosis0.0
(0.0 to 0.0)		0.00%-3.2
(-23.8 to 25.5)
Genital prolapse0.0
(0.0 to 0.0)		0.00%-24.1
(-36.0 to -13.0)
Other gynecological diseases0.1
(0.1 to 0.1)		0.01%-3.6
(-12.2 to 5.9)
Hemoglobinopathies and hemolytic anaemias 1.4
(1.1 to 1.8)		0.19%-11.3
(-17.6 to -4.8)
Thalassemias0.1
(0.1 to 0.1)		0.01%-27.9
(-36.5 to -17.2)
Sickle cell disorders0.5
(0.3 to 0.8)		0.07%-3.1
(-17.6 to 10.3)
G6PD deficiency0.2
(0.2 to 0.3)		0.03%-7.1
(-12.1 to -1.0)
Other hemoglobinopathies and hemolytic anaemias0.6
(0.5 to 0.6)		0.08%-16.1
(-18.7 to -13.4)
Endocrine, metabolic, blood, and immune disorders 1.9
(1.5 to 2.0)		0.26%0.8
(-5.0 to 4.4)
Sudden infant death syndrome 0.6
(0.3 to 1.2)		0.08%-20.2
(-31.2 to -4.9)
III. Injuries57.9
(55.9 to 59.2)		7.85%-13.7
(-15.1 to -12.2)
Transport injuries17.0
(16.4 to 17.4)		2.30%-17.0
(-19.5 to -14.9)
Road injuries 15.8
(15.2 to 16.3)		2.14%-17.1
(-19.7 to -14.9)
Pedestrian road injuries6.2
(5.9 to 6.8)		0.84%-21.4
(-25.5 to -17.9)
Cyclist road injuries0.9
(0.7 to 1.0)		0.12%-8.8
(-14.8 to -2.5)
Motorcyclist road injuries2.9
(2.5 to 3.0)		0.39%-12.4
(-19.5 to -7.3)
Motor vehicle road injuries5.8
(5.4 to 6.0)		0.79%-15.6
(-18.6 to -12.2)
Other road injuries0.1
(0.1 to 0.2)		0.01%-19.4
(-24.1 to -1.3)
Other transport injuries 1.2
(1.1 to 1.4)		0.16%-15.5
(-19.5 to -10.9)
Unintentional injuries23.8
(22.4 to 24.7)		3.23%-15.3
(-17.3 to -12.8)
Falls9.2
(8.5 to 9.8)		1.25%-2.8
(-7.4 to 3.4)
Drowning4.0
(3.8 to 4.1)		0.54%-27.3
(-29.6 to -24.5)
Fire, heat, and hot substances1.6
(1.3 to 1.7)		0.22%-22.9
(-25.4 to -17.3)
Poisonings0.9
(0.7 to 1.0)		0.12%-20.8
(-28.4 to -12.5)
(Poisoning by carbon monoxide)0.5
(0.3 to 0.5)		0.07%-26.6
(-34.8 to -20.3)
(Poisoning by other means)0.5
(0.4 to 0.5)		0.07%-14.4
(-22.4 to -3.9)
Exposure to mechanical forces1.8
(1.5 to 1.8)		0.24%-20.3
(-22.9 to -17.8)
(Unintentional firearm injuries)0.3
(0.3 to 0.3)		0.04%-16.4
(-20.3 to -11.5)
(Other exposure to mechanical forces)1.5
(1.2 to 1.6)		0.20%-21.0
(-23.7 to -18.3)
Adverse effects of medical treatment1.6
(1.4 to 1.8)		0.22%-6.2
(-10.0 to -2.5)
Animal contact1.1
(0.6 to 1.2)		0.15%-16.0
(-20.5 to -9.6)
(Venomous animal contact)0.9
(0.5 to 1.1)		0.12%-16.0
(-21.0 to -9.7)
(Non-venomous animal contact)0.1
(0.1 to 0.2)		0.01%-16.1
(-27.4 to -6.2)
Foreign body1.7
(1.6 to 1.8)		0.23%-14.1
(-17.0 to -11.6)
(Pulmonary aspiration and foreign body in airway)1.6
(1.5 to 1.7)		0.22%-13.9
(-17.0 to -11.4)
(Foreign body in other body part)0.1
(0.1 to 0.1)		0.01%-15.8
(-20.8 to -10.0)
Environmental heat and cold exposure0.7
(0.5 to 0.8)		0.09%-29.4
(-37.1 to -25.4)
Exposure to forces of nature0.1
(0.1 to 0.1)		0.01%-45.8
(-45.8 to -45.8)
Other unintentional injuries1.2
(1.2 to 1.3)		0.16%-25.8
(-27.6 to -23.8)
Self-harm and interpersonal violence17.1
(16.3 to 17.5)		2.32%-7.6
(-9.9 to -5.5)
Self-harm 10.0
(9.4 to 10.3)		1.36%-14.8
(-18.0 to -12.6)
Self-harm by firearm0.8
(0.7 to 1.0)		0.11%-10.3
(-13.9 to -7.2)
Self-harm by other specified means9.2
(8.5 to 9.5)		1.25%-15.2
(-18.4 to -12.8)
Interpersonal violence 5.2
(4.7 to 5.5)		0.70%-11.1
(-13.3 to -8.7)
Assault by firearm2.2
(1.9 to 2.4)		0.30%-3.6
(-6.5 to -0.5)
Assault by sharp object1.2
(0.9 to 1.4)		0.16%-22.3
(-25.6 to -17.6)
Assault by other means1.8
(1.6 to 2.1)		0.24%-11.5
(-15.4 to -7.6)
Conflict and terrorism 1.7
(1.7 to 1.7)		0.23%98.4
(98.4 to 98.5)
Executions and police conflict 0.2
(0.2 to 0.2)		0.03%172.4
(156.8 to 187.6)

By lost years
This section is an excerpt from Years of potential life lost § By main cause of death.[edit]
Person-years of potential life lost in the United States in 2006[5]
Cause of premature death Person-years lost
Cancer8,628,000 person-years
Heart disease and strokes8,760,000 person-years
Accidents and other injuries5,873,000 person-years
All other causes13,649,000 person-years
Person-years of potential life lost in the United States in 2018
Cause of premature death Person-years lost
(Use/Accessibility/... of) firearms1.42 million[6][7]
Motor vehicle crashes1.34 million[7]
All other causes
A study suggests the global 'mean loss of life expectancy' (LLE) from all forms of direct violence was about 0.3 years, while air pollution accounted for about 2.9 years in 2015.[8]

Underlying causes

Malnutrition

Malnutrition can be identified as an underlying cause for shortened life.[9] 70% of childhood deaths (age 0–4) are reportedly due to diarrheal illness, acute respiratory infection, malaria and immunizable disease. However 56% of these childhood deaths can be attributed to the effects of malnutrition as an underlying cause.[10] The effects of malnutrition include increased susceptibility to infection,[11] musculature wasting, skeletal deformities and neurologic development delays.[12] According to the World Health Organization, malnutrition is named as the biggest contributor to child mortality[13] with 36 million deaths in 2005 related to malnutrition.[14]

Air pollution

Overall, air pollution causes the deaths of around ca. 7 million people worldwide each year, and is the world's largest single environmental health risk, according to the WHO (2012) and the IEA (2016).[15][16][17]

The IEA notes that many of root causes and cures can be found in the energy industry and suggests solutions such as retiring polluting coal-fired power plants and to establishing stricter standards for motor vehicles.[17] In September 2020 the European Environment Agency reported that environmental factors such as air pollution and heatwaves contributed to around 13% of all human deaths in EU countries in 2012 (~630,000).[18] A 2021 study using a high spatial resolution model and an updated concentration-response function finds that 10.2 million global excess deaths in 2012 and 8.7 million in 2018 – or a fifth – were due to air pollution generated by fossil fuel combustion, significantly higher than earlier estimates and with spatially subdivided mortality impacts.[19][20]

A 2020 study indicates that the global mean loss of life expectancy (LLE) from air pollution in 2015 was 2.9 years, substantially more than, for example, 0.3 years from all forms of direct violence, albeit a significant fraction of the LLE is considered to be unavoidable.[8]

Non-optimal ambient temperatures

A study found that 9.4% of global deaths between 2000 and 2019 – ~5 million annually – can be attributed to extreme temperature with cold-related ones making up the larger share and decreasing and heat-related ones making up ~0.91 % and increasing. Incidences of heart attacks, cardiac arrests and strokes increase under such conditions.[21][22]

Antimicrobial resistance

In a global assessment, scientists reported, based on medical records, that antibiotic resistance may have contributed to ~4.95 million (3.62–6.57) deaths in 2019, with 1.3 M directly attributed – the latter being more than deaths than from e.g. AIDS or Malaria,[23][24] despite being project to rise substantially.[25]

Aging
See also: Life extension

Traditionally aging is not considered as a cause of death. It is believed that there is always a more direct cause, and usually it is one of many age-related diseases. It is estimated that, as an root cause, the aging process underlies 2/3 of all death in the world (approximately 100,000 people per day in 2007). In highly developed countries this proportion can reach 90%.[26] There are requests of granting aging an official status of a disease and treating it directly (such as via dietary changes and senolytics).[27][28][29][30][31]

Developed vs. developing economies

Top causes of death, according to the World Health Organization report for the calendar year 2001:[32]

Causes of death in developing countriesNumber of deathsCauses of death in developed countriesNumber of deaths
HIV-AIDS2,678,000 Ischaemic heart disease3,512,000
Lower respiratory infections2,643,000 Cerebrovascular disease3,346,000
Ischaemic heart disease2,484,000 Chronic obstructive pulmonary disease1,829,000
Diarrhea1,793,000 Lower respiratory infections1,180,000
Cerebrovascular disease1,381,000 Lung cancer938,000
Childhood diseases1,217,000 Car crash669,000
Malaria1,103,000 Stomach cancer657,000
Tuberculosis1,021,000 Hypertensive heart disease635,000
Chronic obstructive pulmonary disease748,000 Tuberculosis571,000
Measles674,000 Suicide499,000

By age group (in the United States)
Leading causes of death by age group in USA, 2018[33]
Leading causes of death in the United States by age group.[34]
Leading causes of death in the United States, as percentage of deaths in each age group.[34] Perinatal mortality (<1yrs of age) seldom falls in any of these causes.
Death by age group as rate compared to the age group with highest rate.[34]

By occupation

With an average of 123.6 deaths per 100,000 from 2003 through 2010 the most dangerous occupation in the United States is the cell tower construction industry.[35]

Selected occupations with high fatality rates, 2011, in the United States.[36]

See also

References
  1. WHO (2005). "Cancer". Archived from the original on May 18, 2020.
  2. Lozano, Rafael; et al. (Dec 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010" (PDF). Lancet. 380 (9859): 2095–128. doi:10.1016/S0140-6736(12)61728-0. hdl:10536/DRO/DU:30050819. PMID 23245604. S2CID 1541253. Archived from the original (PDF) on February 11, 2020.
  3. World Health Organization, "The top 10 causes of death"
  4. GBD 2017 Causes of Death Collaborators. "Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017". The Lancet. 8 Nov 2018; 392:1736–88. doi:10.1016/S0140-6736(18)32203-7. Table 1.
  5. National Cancer Institute. "Person-Years of Life Lost". Cancer Trends Progress Report, 2009/2010 Update. Archived from the original on July 1, 2011.
  6. "Premature deaths from guns expose another toll of the firearms crisis". Georgia Public Broadcasting. Retrieved 16 March 2022.
  7. Klein, Joshua; Prabhakaran, Kartik; Latifi, Rifat; Rhee, Peter (1 February 2022). "Firearms: the leading cause of years of potential life lost". Trauma Surgery & Acute Care Open. 7 (1): e000766. doi:10.1136/tsaco-2021-000766. ISSN 2397-5776.
  8. Lelieveld, Jos; Pozzer, Andrea; Pöschl, Ulrich; Fnais, Mohammed; Haines, Andy; Münzel, Thomas (1 September 2020). "Loss of life expectancy from air pollution compared to other risk factors: a worldwide perspective". Cardiovascular Research. 116 (11): 1910–1917. doi:10.1093/cvr/cvaa025. ISSN 0008-6363. PMC 7449554. PMID 32123898.
  9. "Mortality In Second And Third Degree Malnutrition". Tropej.oxfordjournals.org. 2014-06-03. Archived from the original on 2016-01-31. Retrieved 2014-06-09.
  10. Pelletier DL, Frongillo EA, Schroeder DG, Habicht JP (2014-01-24). "The effects of malnutrition on child mortality in developing countries". Bull. World Health Organ. 73 (4): 443–48. PMC 2486780. PMID 7554015.
  11. Faulk, W. Page; Demaeyer, E. M.; Davies, A. J. S. (1974-06-01). "Some effects of malnutrition on the immune response in man". The American Journal of Clinical Nutrition. Ajcn.nutrition.org. 27 (6): 638–646. doi:10.1093/ajcn/27.6.638. PMID 4208451. Retrieved 2014-06-09.
  12. Grover, Zubin; Ee, Looi C. (October 2009). "Elsevier". Pediatric Clinics. Pediatric.theclinics.com. 56 (5): 1055–1068. doi:10.1016/j.pcl.2009.07.001. PMID 19931063. Retrieved 2014-06-09.
  13. Stay informed today; every day (2008-01-24). "Malnutrition: The starvelings". The Economist. Retrieved 2014-06-09.
  14. Ziegler, Jean (2007). L'Empire de la honte. Fayard
  15. "7 million premature deaths annually linked to air pollution". WHO. 25 March 2014. Archived from the original on March 26, 2014. Retrieved 25 March 2014.
  16. "Energy and Air Pollution" (PDF). Iea.org. Archived from the original (PDF) on 11 October 2019. Retrieved 12 March 2019.
  17. "Study Links 6.5 Million Deaths Each Year to Air Pollution". The New York Times. 26 June 2016. Retrieved 27 June 2016.
  18. Abnett, Kate (8 September 2020). "One in eight deaths in Europe linked to pollution, environment, EU says". Reuters. Retrieved 9 October 2020.
  19. Green, Matthew (9 February 2021). "Fossil fuel pollution causes one in five premature deaths globally: study". Reuters. Retrieved 5 March 2021.
  20. Vohra, Karn; Vodonos, Alina; Schwartz, Joel; Marais, Eloise A.; Sulprizio, Melissa P.; Mickley, Loretta J. (1 April 2021). "Global mortality from outdoor fine particle pollution generated by fossil fuel combustion: Results from GEOS-Chem". Environmental Research. 195: 110754. Bibcode:2021ER....195k0754V. doi:10.1016/j.envres.2021.110754. ISSN 0013-9351. PMID 33577774. S2CID 231909881. Retrieved 5 March 2021.
  21. "Extreme temperatures kill 5 million people a year with heat-related deaths rising, study finds". The Guardian. 7 July 2021. Retrieved 14 August 2021.
  22. Zhao, Qi; et al. (1 July 2021). "Global, regional, and national burden of mortality associated with non-optimal ambient temperatures from 2000 to 2019: a three-stage modelling study". The Lancet Planetary Health. 5 (7): e415–e425. doi:10.1016/S2542-5196(21)00081-4. ISSN 2542-5196. PMID 34245712. S2CID 235791583.
  23. "Antibiotic resistance killed more people than malaria or AIDS in 2019". New Scientist. Retrieved 12 February 2022.
  24. Christopher JL Murray; et al. (12 February 2022). "Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis". The Lancet. 399 (10325): 629–655. doi:10.1016/S0140-6736(21)02724-0. ISSN 0140-6736.
  25. Chanel S, Doherty B (2020-09-10). "'Superbugs' a far greater risk than Covid in Pacific, scientist warns". The Guardian. ISSN 0261-3077. Retrieved 2020-09-14.
  26. Aubrey D.N.J., de Grey (2007). "Life Span Extension Research and Public Debate: Societal Considerations" (PDF). Studies in Ethics, Law, and Technology. 1 (1, Article 5). CiteSeerX 10.1.1.395.745. doi:10.2202/1941-6008.1011. Archived from the original (PDF) on October 13, 2016. Retrieved August 7, 2011.
  27. Zhavoronkov, Alexander; Bhupinder, Bhullar (2015-10-04). "Classifying aging as a disease in the context of ICD-11". Frontiers in Genetics. 6: 326. doi:10.3389/fgene.2015.00326. PMC 4631811. PMID 26583032.
  28. Stambler, Ilia (2017-10-01). "Recognizing Degenerative Aging as a Treatable Medical Condition: Methodology and Policy". Aging and Disease. 8 (5): 583–589. doi:10.14336/AD.2017.0130. PMC 5614323. PMID 28966803.
  29. "Opening the door to treating ageing as a disease". The Lancet Diabetes & Endocrinology. 6 (8): 587. 2018-08-01. doi:10.1016/S2213-8587(18)30214-6. PMID 30053981.
  30. Calimport, Stuart; et al. (2019-10-01). "To help aging populations, classify organismal senescence". Science. 366 (6465): 576–578. Bibcode:2019Sci...366..576C. doi:10.1126/science.aay7319. PMC 7193988. PMID 31672885.
  31. Khaltourina, Daria; Matveyev, Yuri; Alekseev, Aleksey; Cortese, Franco; Ioviţă, Anca (July 2020). "Aging Fits the Disease Criteria of the International Classification of Diseases". Mechanisms of Ageing and Development. 189: 111230. doi:10.1016/j.mad.2020.111230. PMID 32251691. S2CID 214779653.
  32. "Cause of Death". UC Atlas of Global Inequality. University of California, Santa Cruz. 18 February 2004. Archived from the original on 18 June 2014. Retrieved 2014-06-09.
  33. "Leading causes of death by age group" (PDF). National Center for Injury Prevention and Control. 2018.
  34. "National Vital Statistics Report" (PDF). National Vital Statistics Report, Vol. 50, No. 15. September 16, 2002.
  35. Day, Ryan Knutson, Liz (21 May 2012). "Methodology: How We Calculated the Tower Industry Death Rate".
  36. "Bureau of Labor Statistics; National Census of Fatal Occupational Injuries in 2006" (PDF). Retrieved 2014-06-09.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.